The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices. Medical and ...

PORTAGE, Michigan - Stryker Corporation (NYSE:SYK), a global leader in medical technology with a market capitalization of $150.87 billion, announced a transition in its executive ranks with the ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

The medical device maker plans to buy all of Inari’s common stock for $80 a share, representing a total fully diluted equity value of about $4.9 billion.

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal dilution. Inari shareholders are getting a fair price relative to the ...

Medical technology company Stryker plans to sell its U.S. spinal implants business to investment firm Viscogliosi Brothers ...

Stryker is acquiring Inari Medical for $80 per share in cash, representing a total equity value of approximately $4.9 billion, indicating a strong financial commitment to expand its portfolio.

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Full Year Results “We delivered another year of double-digit organic sales growth ...

Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the issued and (NASDAQ: NARI) for $80.00 ...

NEW YORK, Jan 6 (Reuters) - Medical-device maker Stryker (SYK.N), opens new tab on Monday agreed to acquire Inari Medical (NARI.O), opens new tab, which makes devices that treat patients with ...